SEATTLE--(BUSINESS WIRE)--Croda International Plc (Croda) and The Access to Advanced Health Institute (AAHI) are pleased to announce today the signing of a partnership agreement around innovation and development of adjuvant formulations, under which Croda and AAHI will leverage their combined expertise to make novel vaccine adjuvant formulations globally accessible, thereby advancing next generation, robust and durable vaccines..

西雅图--（商业新闻短讯）--禾大国际股份有限公司（Croda）和先进健康研究所（AAHI）今天很高兴地宣布，双方签署了一项关于佐剂配方创新和开发的合作协议，根据该协议，禾大和AAHI将利用其联合专业知识，在全球范围内提供新型疫苗佐剂配方，从而推进下一代，强大和持久的疫苗。。

AAHI, a leading nonprofit biotech research institute that has developed platform technologies for harnessing the immune system to combat disease, boasts a diverse portfolio of adjuvant formulations used in numerous vaccine candidates targeting major infectious diseases and neglected diseases listed by the World Health Organisation as significant global threats.

AAHI是一家领先的非营利生物技术研究机构，开发了利用免疫系统对抗疾病的平台技术，拥有多种佐剂配方组合，用于针对世界卫生组织列为重大全球威胁的主要传染病和被忽视疾病的众多候选疫苗。

With deep adjuvant and vaccine formulation expertise and years of experience developing cost-effective, sustainable products and processes for making them, AAHI stands at the forefront of vaccine innovation..

凭借深厚的佐剂和疫苗配方专业知识以及多年开发成本效益高、可持续的产品和工艺的经验，AAHI站在疫苗创新的最前沿。。

The exclusive agreement between AAHI and Croda includes a collaborative effort in research and development, combining the unique expertise of both entities, to propel rapid development of innovative adjuvants and formulations, and to develop efficient manufacturing processes to enable production at scale, to meet vaccine industry and global needs.

AAHI和Croda之间的独家协议包括在研究和开发方面的合作，结合两个实体的独特专业知识，推动创新佐剂和配方的快速发展，并开发高效的制造工艺，以实现规模生产，满足疫苗行业和全球需求。

Further, the agreement grants Croda certain rights to market, distribute and sell selected novel adjuvant formulations developed by AAHI, for research purposes and clinical development. Croda will apply its unparalleled cGMP manufacturing expertise as AAHI’s exclusive authorised manufacturer in major countries, to scale up manufacturing and support for phase 3 clinical trials and commercial use..

此外，该协议授予禾大一定的市场营销、分销和销售由AAHI开发的选定新型佐剂配方的权利，用于研究目的和临床开发。作为AAHI在主要国家的独家授权制造商，禾大将应用其无与伦比的cGMP制造专业知识，扩大生产规模，并支持3期临床试验和商业用途。。

Commenting on the partnership, Daniele Piergentili, President Life Sciences at Croda, said “This partnership marks another significant milestone in our endeavour to offer a comprehensive portfolio of adjuvants for the vaccines of tomorrow. It perfectly aligns with our pharmaceutical strategy to “Empower biologics delivery” and underscores our commitment to making substantial contributions to the successful development and commercialisation of WHO-listed pipeline vaccines.

禾大生命科学总裁Daniele Piergentili在评论这一合作关系时表示，“这一合作关系标志着我们努力为明天的疫苗提供全面佐剂组合的另一个重要里程碑。它与我们“增强生物制剂交付能力”的制药战略完全一致”并强调我们致力于为世卫组织列出的管道疫苗的成功开发和商业化做出重大贡献。

The dedication of AAHI to creating sustainable and widely accessible vaccines and immunotherapies aligns seamlessly with our Purpose of employing Smart science to improve lives.”.

AAHI致力于创造可持续和广泛可用的疫苗和免疫疗法，这与我们利用智能科学改善生活的目的无缝结合。”。

Corey Casper, President, and Chief Executive Officer of AAHI, commented, “The opportunities this partnership creates, not only for AAHI but also for our collaborators and vaccine developers who rely on adjuvant formulations for the deployment of effective health solutions, are tremendous. Croda’s commitment to and passion for developing sustainable adjuvant formulation solutions from bench to clinic to market is in direct alignment with our mission to create worldwide access to vaccines and immunotherapies.

AAHI总裁兼首席执行官Corey Casper评论道，（笑声）“这种合作关系不仅为AAHI创造了巨大的机会，也为我们的合作者和疫苗开发人员创造了巨大的机会，他们依靠佐剂配方部署有效的健康解决方案。禾大致力于开发从实验室到诊所再到市场的可持续佐剂配方解决方案，这与我们创造世界的使命直接相关广泛获得疫苗和免疫疗法。

We look forward to working together to make a significant global impact by enabling sustainable and reliable protection against disease.”.

我们期待着共同努力，通过实现可持续和可靠的疾病预防，产生重大的全球影响。”。

Croda Pharma

Croda Pharma

Croda’s Pharma business is a leading partner for the development of excipients and the supply of high purity materials for pharmaceutical formulations, committed to enabling the next generation of drug delivery systems. The business is focused on empowering biologics drug delivery, through its adjuvant systems, small molecule, protein, and nucleic acid delivery platforms.

禾大制药业务是开发赋形剂和为药物制剂提供高纯度材料的主要合作伙伴，致力于实现下一代药物输送系统。该业务专注于通过其辅助系统，小分子，蛋白质和核酸递送平台来增强生物制剂药物递送。

With a wide range of solutions for both human and animal health markets, our pharmaceutical portfolio is unsurpassed in its excellence for drug and vaccine delivery..

凭借针对人类和动物健康市场的广泛解决方案，我们的药物组合在药物和疫苗输送方面具有无与伦比的优势。。

Croda’s products, along with its in-house formulation and regulatory expertise, allow the company to meet its customers most demanding formulation needs.

禾大的产品及其内部配方和监管专业知识使该公司能够满足客户最苛刻的配方需求。

To learn more visit www.crodapharma.com

To learn more visit www.crodapharma.com

About AAHI

关于AAHI

AAHI is a nonprofit biotech research institute located in Seattle, Washington, that combines the high-quality science of an academic research organisation with the product development capabilities of a biotech company to help combat some of the world’s deadliest diseases, including infectious diseases such as Covid-19, mosquito- and tick-borne diseases, cancer, fungal and parasitic infections, and other non-communicable diseases.

AAHI是一家位于华盛顿州西雅图的非营利生物技术研究机构，它将学术研究组织的高质量科学与生物技术公司的产品开发能力相结合，以帮助对抗世界上一些致命的疾病，包括新型冠状病毒（Covid-19）等传染病，蚊子和蜱传疾病，癌症，真菌和寄生虫感染，和其他非传染性疾病。

For nearly three decades, AAHI, previously known as the Infectious Disease Research Institute, has focused on creating immune-enhancing technologies that improve the body’s natural response to disease. Through collaboration, AAHI brings innovative products from the lab to clinic to people, furthering AAHI’s mission to bring together the best experts, technologies, and platforms to create accessible, high-quality products and solutions.

近三十年来，AAHI（以前称为传染病研究所）一直致力于创造免疫增强技术，以改善身体对疾病的自然反应。通过合作，AAHI将从实验室到诊所的创新产品带给人们，进一步推动了AAHI的使命，即汇集最佳专家、技术和平台，创造出可访问的高质量产品和解决方案。

AAHI is working to build a world in which every person has access to tools that harness their immune system and allow them to live a healthy life free of illness and disease..

AAHI正在努力建立一个世界，在这个世界上，每个人都可以获得利用其免疫系统的工具，并使他们能够健康地生活，远离疾病。。

To learn more visit www.aahi.org

要了解更多信息，请访问www.aahi.org